Skip to main content

Table 2 Number and proportion of registries collecting PROMs at various follow up time points stratified by region and condition. Follow up point t0 is the reported baseline time point or time of intervention as specified in the article or report. Follow up point t1 is from 0 to 1 year, follow up point t2 is from 1 to < 2 years, follow up point t3 is from 2 to < 5 years, follow up point t4 is from 5 to < 10 years and follow up point t5 is from 10 + years

From: Response rates in clinical quality registries and databases that collect patient reported outcome measures: a scoping review

Registry type

Follow up points

t0

t1

t2

t3

t4

t5

All registries (n = 121)

92 (76%)

57(47%)

69 (57%)

33 (27%)

12 (10%)

2 (2%)

By region

      

North & South America (33)

27 (82%)

14 (42%)

17 (54%)

7 (21%)

2 (6%)

NA

Scandinavia (31)

24 (77%)

13 (42%)

21 (68%)

8 (26%)

6 (19%)

1 (3%)

Europe (excluding Scandinavia) (20)

18 (90%)

13 (65%)

9 (45%)

6 (30%)

2 (10%)

1 (5%)

Oceania (27)

14 (61%)

13(57%)

17 (74%)

9 (39%)

2 (7%)

NA

Global (8)

7 (88%)

3 (38%)

4 (50%)

2 (25%)

NA

NA

Asia (2)

2 (100%)

1 (50%)

1 (50%)

1 (50%)

NA

NA

By condition

      

Arthroplasty/Reconstruction/Joint related registries (33)

29 (88%)

18 (55%)

21 (64%)

13 (40%)

7 (21%)

1 (3%)

Cancer registries (25)

18 (72%)

8 (32%)

17 (68%)

6 (24%)

3 (12%)

NA

Chronic disease registries (19)

14 (74%)

8 (42%)

8 (42%)

NA

1 (6%)

1 (6%)

Trauma/Burns/Pain registries (10)

6 (60%)

9 (90%)

6 (60%)

4 (40%)

NA

NA

Spine registries (8)

7 (88%)

5 (50%)

7 (88%)

3 (38%)

NA

NA

Miscellaneous registries (7)

7 (100%)

1 (14%)

1 (14%)

4 (50%)

NA

NA

Cardiac registries (6)

3 (50%)

3 (50%)

3 (50%)

NA

NA

NA

General surgery and device registries (5)

3 (60%)

3 (60%)

4 (80%)

3 (60%)

1 (20%)

NA

Rare disease registries (4)

2 (50%)

1 (25%)

NA

NA

NA

NA

Gynaecological registries (4)

3 (75%)

1 (25%)

2 (50%)

NA

NA

NA